Across TCGA pan-cancer cohorts, EPPIN-WFDC6 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of EPPIN-WFDC6’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where EPPIN-WFDC6 RNA is repressed in tumor relative to normal tissue. In most cancer types EPPIN-WFDC6 is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.
LUAD, LUSC, and THCA are the cancer types where EPPIN-WFDC6 tumor–normal differential expression is most reproducible.